Inogen (INGN) Operating Expenses (2013 - 2026)

Inogen (INGN) has 14 years of Operating Expenses data on file, last reported at $47.2 million in Q1 2026.

• Operating Expenses for Q1 2026 came in at $47.2 million, up 7.2% year-over-year; the trailing twelve-month figure through Mar 2026 was $187.6 million (down 1.57% YoY), and the FY2025 annual result was $184.5 million, down 6.48% from the prior year.
• Operating Expenses grew to $47.2 million in Q1 2026 per INGN's latest filing, from $44.5 million in the prior quarter.
• Over five years, Operating Expenses peaked at $88.0 million in Q4 2022 and troughed at $44.0 million in Q1 2025.
• A 5-year average of $53.2 million and a median of $49.1 million in 2022 frame the typical range for Operating Expenses.
• The sharpest annual moves came in 2022 and 2024: Operating Expenses soared 94.34% in 2022, then plunged 38.95% in 2024.
• A 5-year view of Operating Expenses shows it stood at $88.0 million in 2022, then slumped by 35.04% to $57.1 million in 2023, then retreated by 16.56% to $47.7 million in 2024, then dropped by 6.57% to $44.5 million in 2025, then increased by 5.97% to $47.2 million in 2026.
• Business Quant data shows INGN's Operating Expenses at $47.2 million in Q1 2026, $44.5 million in Q4 2025, and $48.4 million in Q3 2025.